Another study investigating the impact of AXL on EGFR‐TKI efficacy has shown that activation of AXL was associated with poor outcome of EGFR‐TKIs.24 However, we did not detect a tendency for OS or PFS to be shorter in EGFR‐mutated NSCLC patients with high levels of AXL or GAS6 in pretreatment tissue or plasma specimens. Here, EGFR is linked to non-small cell lung carcinoma.